OECD Expert Meeting on eHealth Indicators

empiricaBoth the European Union and the World Health Organisation (WHO) have recognised ICT-facilitated solutions as key enablers for modern, patient-centered and efficient healthcare services. To support health policies, it has become mandatory to monitor and benchmark Health ICT (eHealth) adoption and use. This is also a priority topic for EU/USA cooperation in the field of eHealth. The OECD plans to coordinate global activities, including involvement of WHO, to develop appropriate approaches and measuring tools.

empirica's director Werner B. Korte and eHealth expert Dr. Veli N. Stroetmann were invited to participate in an OECD expert meeting on May 25 on measuring the progress of global eHealth diffusion. Currently, indicators on eHealth availability and use are not uniform, and do not cover all OECD countries. The European Commission funded empirica studies on eHealth Indicators and eHealth Benchmarking compiled a comprehensive inventory of available statistical evidence on eHealth in Europe, Canada and the USA. This research also developed an indicator framework to support and guide the development of and agreement on a comprehensive set of key global indicators and procedures for data gathering on eHealth. Furthermore, detailed policy recommendations were drafted to take the work on indicators forward. Werner B. Korte and Veli Stroetmann presented the results of these studies at the OECD meeting in Paris and discussed together with other country and OECD/WHO experts and policy makers how to harmonise key global indicators, including how best to coordinate national and European surveys to comparatively measure eHealth progress.

"empirica is proud to have its long standing expertise in eHealth as well as indicator development, monitoring and benchmarking recognised at the level of the OECD and will continue to monitor and assess the eHealth landscape in Europe," concluded Werner B. Korte.

For further information, please visit:

Related news articles:

About empirica
empirica Communication and Technology Research is a private research institute founded in 1976 and based in Bonn, Germany. It specialises in communication and information technology related research and consultancy to clients in both the private and public sector. Its body of expertise ranges from long-term RTD roadmapping, policy and strategy development to pilot trials and EU-wide representative market research. The company has gained a strong profile in the practical development, pilot-testing and market validation of IST-based healthcare services. It observes and interprets market trends and evaluates the socio-economic impact of eHealth applications. In addition, it regularly conducts foresight exercises, representative surveys and compiles data bases of good practice case studies with the support of a dense network of contacts in government, industry and academia. For further information, please visit www.empirica.com.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...